Brief: ASIT Biotech reports results of phase III clinical trial

European Medical Solutions SA

28/02/2017 17:11

Feb 28 (Reuters) - ASIT Biotech SA  ASIT.BR : 
    * Reports positive results in its phase III clinical trial 
with gp-ASIT+ for grass pollen induced allergic rhinitis 
    * Says results allow further discussions with regulatory 
agencies in Germany and the US regarding gp-ASIT+ clinical 
development 
    * First ever clinical study to demonstrate the clinical 
efficacy of allergen peptides in a real-life setting 
 
Source text: http://bit.ly/2mBnTyr 
Further company coverage:  ASIT.BR  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))